Studies have suggested the implant had higher failure rates than traditional hip replacements and has failed in some patients only a few years after implant due to metallic debris caused by an improperly implanted hip, according to the report.
Some physicians are criticizing DePuy for not stopping sales of the device earlier as evidence of the failing implants has been available “for some time,” according to the report.
Read the New York Times´ report on the DePuy ASR hip implant.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
